Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression - Kramer, MS; Winokur, A; Kelsey, J; Preskorn, SH; Rothschild, AJ; Snavely, D (Neuropsychopharmacology, 2004)
et al.